Avastin + Tarceva = better results in lung cancer - Genentech said the trial was stopped early after an interim analysis found that combining Avastin, known generically as bevacizumab, and Tarceva, or …
Pharma News 9_12
King begins hostile takeover proceedings with Alpharma - Brain Markison, King’s ceo, is disappointed that Dean Mitchell, Alpharma’s ceo, hasn’t responded to his initial offer $1.4 billion offer, which …